
Ashwin Pharmaceuticals Private Limited
Pharmaceutical company manufacturing and trading various types of medicines.
Pharmaceutical company manufacturing and trading various types of medicines.
Delhi, India
+91-XXXXXXXXXX
U51101DL2013PTC259819
259819
Private Limited Indian Non-Government Company
01 Nov 2013
27 Sep 2021
31 Mar 2021
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pranav Srivastava ![]() | Director | 28-Apr-2016 | Current |
Aditya Bhandari ![]() | Director | 12-Sep-2018 | Current |
Ashwin Pharmaceuticals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 219.04% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2018, Ashwin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Aditya Bhandari is a mutual person
Aditya Bhandari is a mutual person
Aditya Bhandari is a mutual person
Aditya Bhandari is a mutual person
Pranav Srivastava is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ashwin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ashwin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ashwin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ashwin Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2021 as per latest MCA records.
Ashwin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi.
Aditya Kumar Bhandari was appointed as a Director was appointed as a Director on 12 Sep 2018 & has been associated with this company since 6 years 6 months .
Pranav Srivastava was appointed as a Director was appointed as a Director on 28 Apr 2016 & has been associated with this company since 8 years 11 months .
Ashwin Pharmaceuticals Private Limited was registered on 01 Nov 2013 with Roc Delhi & aged 11 years 4 months as per MCA records.
Ashwin Pharmaceuticals Private Limited was incorporated on 01 Nov 2013.
The authorized share capital of Ashwin Pharmaceuticals Private Limited is ₹ 1.40 Cr and paid-up capital is ₹ 9.40 M.
Currently 2 directors are associated with Ashwin Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Ashwin Pharmaceuticals Private Limited is C-30 Panchsheel Enclave India, New Delhi, 110017.
The corporate identification number (CIN) of Ashwin Pharmaceuticals Private Limited is U51101DL2013PTC259819 and the company number is 259819 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2018 indicates that The net worth of Ashwin Pharmaceuticals Private Limited has experienced an downturn of -0.03%.
The most recent Balance Sheet for Ashwin Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2021.
JM